Presbyopia News

Brimochol PF, a once-daily eye drop under evaluation for the treatment of presbyopia, achieved primary and secondary endpoints in the pivotal phase 3 BRIO-I clinical trial, according to a press release from Visus Therapeutics.

TAMPA, Fla. — In this Healio Video Perspective from the Telling It Like It Is meeting, Brian M. Shafer, MD, shares his thoughts on managing astigmatism or presbyopia at the time of cataract surgery.

VILAMOURA, Portugal — At the ESCRS winter meeting, Florian Kretz, MD, speaks about the importance of offering the whole range of innovative technologies in a modern clinic.

VILAMOURA, Portugal — In this Healio Video Perspective at the ESCRS winter meeting, José L. Güell, MD, speaks about the use of phakic IOLs in presbyopic myopes.

The FDA approved a twice-daily dosing option for Vuity for the treatment of presbyopia, AbbVie announced.

Visus Therapeutics completed enrollment in a pivotal phase 3 trial investigating Brimochol PF for the treatment of presbyopia.

Lenz Therapeutics has raised $83.5 million in an oversubscribed Series B financing, according to a press release.

VILAMOURA, Portugal — In this Healio Video Perspective from the ESCRS winter meeting, Gerd Auffarth, MD, PhD, gives pearls on how to match advanced-technology IOLs to patient needs in presbyopic lens exchange.

TAMPA, Fla. — Not all patients are good candidates for receiving presbyopic IOLs, but for those who are, preoperative testing helps ensure good refractive results, a speaker said here.

A study conducted in the United Kingdom found “excellent” outcomes for Presbyond laser blended vision LASIK in pilots requiring Class 1 certification.